Fixed Tools to Foundational Platforms: The 2027 Clinical AI Strategy

For years, clinical AI was adopted in a straightforward way: find a specific clinical problem, such as detecting a brain bleed on a CT scan, and buy a specialized, FDA-cleared tool to address it. These tools worked well for single procedures, but by 2027, this direct-to-vendor approach will no longer work.

We are seeing a major shift in the market. People are realizing that adding more and more clinical AI solutions to a single study brings limited productivity gains and rising costs. Leading health systems are now moving toward Foundational Models, reusable platforms that can be used for many different tasks.

The Patchwork Problem: Why Point Solutions Don't Scale

Take a typical CT Chest study. A radiologist usually checks for more than 20 conditions, such as pulmonary nodules, PE, emphysema, and coronary artery calcification. In the old model, covering all these findings meant using up to a dozen different vendors, which is expensive and hard to manage.

If fully adopted, an average practice could end up using more than 100 AI models just in radiology. This could actually quadruple the amount of data a radiologist sees for each patient, making their job harder instead of easier.

 

"Pixels to Paragraphs": The Foundation Model Advantage

The key advantage in 2026 is shifting from single-purpose tools to adaptive, multimodal Foundation Models. This move takes us from just analyzing images to generating full reports, “Pixels to Paragraphs.”

  • Legacy Models (510k): These are static tools that only use image data and focus on a single use case.
  • Foundation Models: These are adaptive systems that combine image data with clinical information to support decisions across many conditions.

The goal isn’t just "catching a finding," but delivering a comprehensive pre-drafted report. With that goal in mind, GenAI can potentially handle up to 90% of the workload for routine, low-acuity cases, which accounts for 65-70% of total volume, allowing clinicians to focus their expertise on the most complex studies.

Real-World Impact: The 40% Efficiency Gain

But here's what separates real productivity gains from chaos: a platform manages what dozens of point solutions cannot. Without a unified approach, each model lives in its own island. One vendor's output doesn't talk to another's. Workflows break. Clinicians jump between tools. IT teams spend their time stitching together integrations instead of scaling what works. A platform approach changes this.

It collectivizes, standardizes, and organizes all those model outputs into a single clinical workflow. Instead of managing 100 separate integrations, IT maintains one deployment fabric. Instead of 100 separate security reviews, one governance framework covers the entire portfolio. Instead of clinicians hunting through vendor dashboards, they see unified results where they work, in their existing systems, at the moment of care.

This is already happening. Real-world data published in JAMA Network Open (June 2025) shows that generative AI systems built in-house at places like Northwestern Medicine can increase radiologist productivity by up to 40%. In actual clinical care, these systems improved documentation efficiency by 15.5% without affecting clinical accuracy.

Actionable Strategy: Bringing Foundations Home

To go from a small pilot to a widely used digital tool, senior leaders in health systems need to focus on how these models are deployed and governed.

1.Ensure Local Accuracy: Foundation models work well out of the box, but they need to be adjusted locally to reach a clinical grade that fits your patient population.

2.Standardize the Deployment Fabric: Avoid creating more isolated systems. Invest in a platform that lets you manage over 100 models as easily as managing just one.

3.Keep AI Secure: Enterprise-grade AI should run within your own security boundaries. As Google’s preferred MedGemma deployment partner, Ferrum Health lets you retrain these models on your local data and deploy them securely behind your firewall.

Bridging the Governance Gap

Moving to Foundational Models is the only way to handle growing volumes without burning out clinicians. By switching from many fixed tools to a stable foundational platform, clinical AI becomes more than just a cost; it becomes a lasting source of revenue and safety for the future.

 

David Hilderbrand

David Hilderbrand has spent 31 years building commercial operations that scale across borders, cultures, and complex healthcare markets. ‍ He served as EVP of Revenue at Blackford, where he developed the partnership strategy that led to a successful acquisition by Bayer Healthcare. Before that, he was Executive VP of Global Sales at Rhapsody, an HG Capital-owned company, where he set up the global structure that secured growth and revenue. At Bayer Healthcare, he built the informatics initiative for EMEA as Head of Informatics for the Radiology Business Unit, working out of Berlin. Earlier in his career, he led commercial operations for EMEA at Vital Images as VP of Sales and Marketing, based in Edinburgh, Scotland. ‍ The through line across all of it: he knows how to build revenue engines in healthcare technology, navigate international markets, and position companies for growth and successful exits. ‍ At Ferrum, David leads all commercial operations as Chief Commercial Officer. He is responsible for scaling the business, building the revenue strategy, and establishing the commercial foundation that turns Ferrum's platform advantage into market leadership. ‍ David serves as Commercial Chair of the CARS Foundation, bringing his decades of experience in healthcare imaging and informatics to help advance the field. ‍ He has worked across continents, built teams in multiple countries, and operated in some of the most complex healthcare markets in the world. He brings that perspective to Ferrum every day.

Related posts

Search Observability Lens: Vendor Neutral Ground Truth
The Breast Imaging AI Market Is Consolidating. That’s Actually Good News. Search